An internal ribosomal entry site (IRES) that directs the initiation of viral protein translation is a potential drug target for enterovirus 71 (EV71). Regulation of internal initiation requires the interaction of IRES trans-acting factors (ITAFs) with the internal ribosomal entry site. Biotinylated RNA-affinity chromatography and proteomic approaches were employed to identify far upstream element (FUSE) binding protein 2 (FBP2) as an ITAF for EV71. The interactions of FBP2 with EV71 IRES were confirmed by competition assay and by mapping the association sites in both viral IRES and FBP2 protein. During EV71 infection, FBP2 was enriched in cytoplasm where viral replication occurs, whereas FBP2 was localized in the nucleus in mock-infected cells. The synthesis of viral proteins increased in FBP2-knockdown cells that were infected by EV71. IRES activity in FBP2-knockdown cells exceeded that in the negative control (NC) siRNA-treated cells. On the other hand, IRES activity decreased when FBP2 was overexpressed in the cells. Results of this study suggest that FBP2 is a novel ITAF that interacts with EV71 IRES and negatively regulates viral translation.
INTRODUCTION
Enterovirus 71 (EV71), a positive-stranded RNA virus of the Picornaviridae family, poses a persistent global public health problem. EV71 presents most frequently as a child herpangina or exanthema, known as hand, foot and mouth disease (HFMD). However, acute EV71 infection is also associated with severe neurological complications with significant mortality. Children under 5-year-old are particularly susceptible to the most severe forms of EV71-associated neurological complications, including aseptic meningitis, brainstem and/or cerebellar encephalitis, myocarditis, acute flaccid paralysis and rapid fatal pulmonary edema and hemorrhage (1) . Such presentations as well as a poliomyelitis-like syndrome have been observed during outbreaks in Taiwan, mainland China, Malaysia, Singapore, western Australia, the United States and Europe (2) (3) (4) (5) (6) (7) (8) . With the emergence of EV71 worldwide as the major causative agent of HFMD fatalities in recent years, and in the absence of any effective anti-enteroviral therapy, a need clearly exists to find a specific anti-EV71 agent. The internal ribosomal entry site (IRES) of EV71 is a good target for the development of an antiviral agent because viral replication can be restricted by inhibiting IRES-mediated viral translation.
A 40S ribosomal subunit recognizes a sequence, RNA structure or ribonucleoprotein complex within the IRES, and initiation occurs at the authentic start codon of the picornaviral RNA. During infection by poliovirus (PV), human rhinovirus (HRV), EV71 or coxsackievirus, the viral proteases 3C and 2A cleave cellular proteins, including the translation initiation factor eIF4G, causing rapid termination of the host cap-dependent translation (9) (10) (11) (12) . The IRES-mediated initiation of translation allows viral RNA translation while host cell translation is shut down during infection. IRES-dependent translation depends on both canonical translation initiation factors and IRESspecific trans-acting factors (ITAFs). These ITAFs interact with various IRES elements to regulate their activities by affecting ribosome recruitment or modifying the structure of the IRES itself. Several proteins that modulate the picornaviral IRES function as ITAFs have been identified: these include polypyrimidine tract binding protein (PTB), poly(rC)-binding protein 1 (PCBP1), poly(rC)-binding protein 2 (PCBP2), autoantigen La, upstream N-ras protein (Unr) and ITAF 45 (13) (14) (15) (16) .
Only a few investigations have described the IRES for EV71 (12, 17) , and the ITAFs for EV71 have not been intensively studied. This work reports the use of the biotinylated RNA-protein pull-down approach followed by matrix-assisted laser desorption ionization/time-of-light mass spectrometer (MALDI-TOF) analysis, to identify 12 cellular proteins that are associated with EV71 5 0 UTR which contains IRES in SF268 cells. Three of these-PTB, PCBP1 and PCBP2-shown have already been demonstrated to interact with the 5 0 UTR of picornavirus (18) (19) (20) . This investigation identifies FBP2 as one of the cellular proteins that is associated with the EV71 5 0 UTR in vitro and in vivo. The interaction between FBP2 and EV71 5 0 UTR was further confirmed by mapping the interaction regions in both viral RNA and FBP2 protein.
The localization of FBP2 in EV71 infected-cells was examined and the role of FBP2 in viral translation was also investigated.
MATERIALS AND METHODS

Plasmid construction
The pT7-EV71 5 0 UTR was constructed as follows: the 5 0 UTR of EV71 was amplified by PCR from the EV71 full-length infectious cDNA clone (21) using EV71 5 0 -(GCCGGTAATACGACTCACTATAGGGAGATTA AAACAGCCTGTGGGT) and EV71 5 0 -(CATGTTTGA TTGTGTTGAGGGTCAAAAT) primers that contained the T7 promoter, and was cloned into pCRII-TOPO vector by TA cloning (Invitrogen, California, USA).
pCMV-tag2B-KSRP (a gift from Dr. Roberto Gherzi, Istituto Nazionale per la Ricerca sul Cancro, Italy) was utilized to construct various truncated forms of flagtagged KH motifs of FBP2, and fragments were amplified by PCR using a 5 0 primer that contained an EcoR I site and a 3 0 primer that contained a Xho I site. PCR products were subcloned between the EcoR I and Xho I sites of pCMV-tag2B vector.
The pRHF was constructed as follows: Renilla Luciferase gene (R) was inserted in EcoR I site of pTriEx-4; Firefly Luciferase gene (F) was inserted in Xho I of pTriEx-4; A hairpin (H) was inserted downstream of the Renilla Luciferase gene to prevent ribosome read-through. A dicistronic reporter plasmid, pRHF-EV71-5 0 UTR, containing EV71 5 0 UTR between Renilla and Firefly luciferase was constructed by insert a Not I-EV71-5 0 UTR-Not I fragment to pRHF.
Preparation of SK-N-MC, SF268 and RD cell extracts SK-N-MC (human neuroblastoma), SF268 (human glioblastoma) and RD (human embryonal rhabdomyosarcoma) cells were grown in Dulbecco's Modified Eagle medium (GIBCO, California, USA) supplemented with 10% fetal bovine serum. Upon confluence, cells were pelleted, washed three times with cold PBS, resuspended in CHAPS buffer (10 mM Tris-HCl pH 7.4, 1 mM MgCl 2 , 1 mM EGTA, 0.5% CHAPS, 10% glycerol, 0.1 mM PMSF, 5 mM 2-ME), and then incubated on ice for 30 min for swelling. Cell lysates were isolated by centrifugation at 10 000g for 10 min at 48C, and the supernatants were collected for further analysis. The concentrations of the proteins in the cell extracts were determined using the Bio-Rad protein assay (Bio-Rad, Hercules, CA).
In vitro transcription
The T7 promoter-EV71-5 0 UTR fragment that was flanked by EcoR I sites was excised from the pCRII-TOPO vector. RNA transcripts were synthesized using the MEGAscript T7 kit (Ambion, Texas, USA), according to the protocol provided by the manufacturer. Biotinylated RNA was synthesized in a 20 ml MEGAscript transcription reaction mixture by the addition of 1.25 ml of 20 mM biotinylated UTP, Bio-16-UTP, which is a substrate for SP6, T3 and T7 RNA polymerases and can replace UTP in the in vitro transcription for RNA labeling (Roche, Penzberg, Germany). Synthesized RNAs were purified using the RNeasy Protect Mini Kit (Nobel, Hilden, Germany) and analyzed on 1% agarose gels.
Isolation of proteins associated with EV71 5' UTR RNA sequences by affinity binding to biotinylated RNA A reaction mixture that contained 200 mg of cell extracts and 12.5 pmol of a biotinylated EV71 5 0 UTR RNA probe was made. The mixture (with a final volume of 100 ml), which contained 5 mM HEPES pH 7.1, 40 mM KCl, 0.1 mM EDTA, 2 mM MgCl 2 , 2 mM dithiothreitol, 1 unit RNasin and 0.25 mg/ml heparin (RNA mobility shift buffer), was incubated for 15 min at 308C, and then added to 400 ml of Streptavidin MagneSphere Paramagnetic Particles (Promega, Wisconsin, USA) for binding for 10 min at room temperature. The protein-RNA complexes were washed five times with the RNA mobility shift buffer without heparin. After the last wash, 30 ml of 2 Â SDS-PAGE sample buffer was added to the beads, which were then incubated for 10 min at room temperature to dissociate the proteins from the RNA. The sample that contained the eluted proteins was then boiled, subjected to 8-16% SDS-PAGE, and further visualized by silver staining or western blotting. Proteins bands were excised and identified by in-gel trypsin digestion and analyzed by Bruker Ultraflex MALDI-TOF mass spectrometry.
Database-searching algorithm
After the masses that were derived from the standards, trypsin, matrix and keratins had been removed, the monoisotopic mass lists for each protonated peptide were used to search the database. Mass lists were exported to the Biotool 2.0 software package to perform peptide mass fingerprinting via Mascot (http://www.matrixscience.com) algorithm scoring to identify proteins.
Western blot analysis
PVDF membranes were blocked with Tris-buffered saline/ 0.1% (vol/vol) Tween 20 that contained 5% non-fat dry milk and probed with the indicated antibodies. The antibodies against FBP2 (1:200; Santa Cruz Biotechnology, Santa Cruz, CA, USA), PTB (1:500; Santa Cruz Biotechnology, Santa Cruz, CA, USA), flag (1:2000; SIGMA, Missouri, USA) and actin (1:5000; Chemicon, USA) were used. After washing, the membrane was incubated with HRP-conjugated anti-mouse antibody or HRP-congugated anti-goat antibody, as appropriate (diluted 1:5000). HRP was detected using the Western Lightning Chemiluminescence Kit, following the manufacturer's protocol (Amersham Pharmacia, Freiburg, Germany).
Coimmunoprecipitation and RT-PCR
Cell extracts from EV71-infected RD cells for use in coimmunoprecipitation assays were prepared at 6 h postinfection. Lysates were precleared by incubation on ice for 1 h with protein A-agarose (50% in lysis buffer) that was bound to non-specific antibody. Non-specific complexes were pelleted by centrifugation at 10 000g at 48C for 10 min. The supernatants were removed and used in the immunoprecipitation assay. Next, 100 ml of precleared lysate was diluted with 450 ml of lysis buffer and then added to 15 ml of flag antibody, before incubation on ice for 2 h. Prewashed protein A-agarose [100 ml in PBS (50:50)] was added to each sample, which was then incubated on ice for an additional hour. Immune complexes were pelleted by centrifugation at 1000g at 48C for 5 min and washed three times with lysis buffer. Each pellet [or 100 ml of precleared lysate (total RNA)] was resuspended in 400 ml of proteinase K buffer [100 mM Tris-HCl (pH 7.5), 12.5 mM EDTA, 150 mM NaCl, 1% SDS] and incubated with 100 mg of predigested proteinase K for 30 min at 378C. RNA was extracted with phenol-chloroform, precipitated in ethanol at -208C for 1 h, washed in 70% ethanol, dried and resuspended in 20 ml DEPC H 2 O. RT-PCR was performed using a Reverse-iT One-Step TR-PCR kit (ABgene, Surry, UK) and either primers specific to EV71 5 0 UTR or primers specific to ribosomal protein S16 (GCGCGGTGAGGTTGTCTAGTC and GAGTTTTG AGTCACGATGGGC).
Fluorescence microscopic analysis
RD cells grown on glass cover slips were infected with EV71 for 1 h at an MOI of 40. After 6 h post-infection, the culture medium was removed, and the cells washed three times with PBS. The cells on the coverslip were fixed with 3.7% (wt/vol.) formaldehyde at room temperature for 20 min. After being washed three times with PBS, the cells on the coverslip were permeabilized in 0.5% Triton X-100 at room temperature for 5 min and washed again three times with PBS. 
Virus infections and metabolic radiolabeling
Forty-eight hours after siRNA transfection, 2 Â 10 5 RD cells were seeded into 12-well plates and incubated at 378C for 24 h. The cells were then infected with EV71 at a multiplicity of infection of 40 PFU per cell. Virus was adsorbed at room temperature for 1 h. The medium was then replaced with methionine-free DMEM, and incubation was continued at 358C. At various times post-infection, the medium was replaced with medium with 35 S-Met labeling (50 mCi/ml). After 1 h of labeling, the cell monolayers were washed with PBS and lysed with lysis buffer. Cell lysates were isolated by centrifugation at 10 000g for 10 min at 48C, and the supernatants were collected for further analysis. Radiolabeled proteins were resolved by SDS-PAGE (12% gels), transferred to a PVDF membrane, and detected by autoradiography. The same membrane was used for Western blotting. The sequence of FBP2 siRNA is 5 0 -CACAUUCGUAUUCUGAGAUCC GUCC-3 0 (Invitrogen, KHSRP-HSS112554); and the sequence of NC siRNA is 5 0 -AACUGGGUAAGCGGG CGCAAAUU-3 0 .
Dicistronic or monocistronic expression assay
For dicistronic expression assay, RD cells were firstly transfected with either FBP2 siRNA or pFBP2/FLAG. After 3 days, dicistronic construct pRHF or pRHF-EV71-5 0 UTR and siRNA duplexes were cotransfected into RD cells with siRNA duplex. After 2 days, cell extracts were prepared in passive buffer (Promega) and assayed for Renilla luciferase (RLuc) and Firefly luciferase (FLuc) activity in a Lumat LB9507 bioluminometer using a dual-luciferase reporter assay (Promega) according to the manufacturer's instructions. For western blotting experiment, cell lysates were incubated at 958C for 5 min, and an equal amount of proteins was resolved on sodium dodecyl sulfate (SDS)-12% polyacrylamide gels. For capped dicistronic mRNA containing a poly(A) tail reporter or monocistronic RNA reporter assay, RD cells transfected with either FBP2 siRNA or FBP2/FLAG were grown for 3 days and then transfected with RNA. After 6-h post-transfection, cells were harvested, lysed and western blotted for FBP2, FBP2/FLAG and actin.
Evaluating RNA replication by slot blotting RD cells were transfected with FBP2 and NC (negative control) siRNA for 48 h, and then trypsinzed and counted. About 2 Â 10 5 cells were seeded into 12-well plates. After 24 h, the cells were then challenged with EV71 (4643/TW/ 1998) at a multiplicity of infection (MOI) of 40 per cell and were harvested at 1, 2, 3, 4, 5, 6, 7, 8 and 9 h postinfection. RNA were extracted and dissolved in a solution of formaldehyde and 20Â SSC for 30 min at 608C. The reaction was then loaded onto a nitrocellulose sheet in the slot-blot manifold. After two washings, the nitrocellulose was removed, air-dried and crosslinked in a Stratalinker at 200 J for 9 min. The nitrocellulose was prehybridized at 688C for 30 min in DIG Easy Hyb (Roche, Germany). DIG-labeled RNA probes, specific for either the genome or the antigenome were produced using DIG Northern Starter kit (Roche, Germany). Following the addition of the probes at 100 ng probe/ml, the blots were incubated at 688C for 16 h. Following the hybridization, the membrane was immediately submerged in the tray that contained Low Stringency Buffer (2 Â SSC with 0.1% SDS) at room temperature for 5 min with shaking. Then, the blot was incubated twice (2 Â 15 min, with shaking) in High Stringency Buffer (0.1 Â SSC with 0.1% SDS) at 688C. The membrane was then incubated with wash buffer for 2 min at room temperature with shaking. After the membrane had been blocked with blocking solution for 30 min, it was incubated with the anti-Digoxigenin-AP antibody solution for 30 min and then washed twice with washing buffer (0.1 M Maleic acid, 0.15 M NaCl; pH 7.5; 0.3% (v/v) Tween 20). It was then equilibrated for 5 min in 20 ml detection buffer (0.1 M Tris-HCl, 0.1 M NaCl, pH 9.5). Finally, the chemiluminescent substrate (CDP-Star) was added to the membrane and the membrane was exposed to a Kodak film.
Expression and purification of recombinant PTB protein PTB cDNA that was derived from SF268 cellular mRNA was cloned into PET30a, a prokaryotic expression vector that contained a histidine tag (Novagen Inc., Madison, Wisc., USA), via restriction sites EcoR I and Hind III. After the constructed plasmid (pET30a/PTB) was introduced into a competent cell E. coli BL21 (DE3 pLysS), His-PTB fusion protein expression was induced with 40 mM isopropyl b-D-thiogalactopyranoside (IPTG) at 378C for 2 h. The recombinant protein was then purified using a HisTrap TM kit (Pharmacia, NJ, USA). The concentration of the protein was measured by Bio-Rad protein assay (Bio-Rad).
RESULTS
FBP2 associates with EV71 5' UTR
To gain a better understanding of the function of EV71 5 0 UTR that contains IRES, biontinylated RNA-affinity chromatography, followed by matrix-assisted laser desorption ionization/time-of-flight mass spectrometry (MALDI-TOF MS), was performed to isolate and identify cellular proteins that associate with EV71 5 0 UTR RNA. The full-length sequence of EV71 5 0 UTR that retains full activity and maintains the correct secondary structure of IRES was employed. Streptavidin beads were used to capture biotinylated EV71 5 0 UTR bound to cellular proteins. Figure 1A presents the results of a biotinylated RNAaffinity chromatography assay. Lane 1 presents the control without any RNA. The patterns of the pull-down protein bands of the control and SF268 cell lysates that were incubated with biotin-16-UTP (lane 2) were identical. When the cell lysates were reacted with biotinylated EV71 5 0 UTR, at least 16 bands with distinct sizes (lane 4) were present in the SF268 cells, suggesting that these proteins may be associated specifically with the EV71 5 0 UTR. In the reactions of cell extracts with non-biotinylated EV71 5 0 UTR, the patterns of the protein bands (lane 3) were identical to those of the controls.
The protein bands that were specifically associated with biotinylated EV71 5 0 UTR RNA (lane 4) in Figure 1A were then extracted, digested with trypsin, and subjected to MALDI-TOF MS analysis. Table 1 presents these proteins with their accession numbers obtained from the protein database. Sixteen bands, presenting 12 proteins, were identified. They comprised three known ITAFs that interacted with the IRES of picornavirus. They were polypyrimidine tract-binding protein (PTB, bands 11-1 and 11-2), poly(C) binding protein 2 (PCBP2, bands 12 and 13) and poly(C) binding protein 1 (PCBP1, band 14).
One novel protein far upstream element binding protein 2 (FBP2, band 5) was chosen and its functions on EV71 5 0 UTR were investigated. To confirm the interaction between the EV71 5 0 UTR and FBP2, the RNA-protein pull down assay was performed as described, and different amounts of non-biotinylated EV71 5 0 UTR or yeast tRNA was added for competition assay. As revealed by Figure 1B , this interaction was out-competed by non-biotinylated EV71 5 0 UTR (lanes 3, 4 and 5) but not by yeast tRNA (lanes 8, 9 and 10), demonstrating that FBP2 does not interact non-specifically with any RNA sequence.
The above experiments were conducted in SF268 cells. To know whether the interactions also occurred in other cells, RNA-protein pull down assay was performed in various cell extracts. As shown in Figure 1C 
Interaction regions in viral RNA and in FBP2 protein
EV71 5
0 UTR contains cloverleaf and IRES structures, verifying and elucidating in greater detail the interaction between EV71 5 0 UTR and FBP2, enabling the binding regions in both viral RNA and FBP2 protein to be further mapped. Figure 2A presents the potential secondary structure of EV71 5 0 UTR as predicted by M-FOLD. Various truncated forms of viral RNAs, as displayed in Figure 2B , were synthesized by in vitro transcription and labeled with biotin. The aforementioned RNA protein pulldown assay was performed, and the streptavidin beads were used to capture the biotinylated viral RNA and its associated cellular proteins from SF268 cells. Western blot was then conducted to measure the interactions of FBP2. As presented in Figure 2B FBP2 contains a proline/glycine-rich N-terminus with a nuclear localization signal, a central region with four KH-type RNA-binding domains and an unusual C terminus rich in glutamine with four degenerate copies of the repeat DYTKAWEEYYKK. An attempt was made to identify the domains within FBP2 that are involved in the interaction with EV71 5 0 UTR. Different truncated forms of DNA constructs were generated to express 0 UTR. RNA-protein pull-down experiments were performed as described in Materials and methods section. EV71 5 0 UTR was labeled with biotin and incubated with SF268 cell lysate (200 mg) for 15 min at 308C. Streptavidin was then used to pull down biotin-labeled RNA (EV71 5 0 UTR) and its associated cellular proteins (lane 4). After they had been washed and dissociated from RNA, the eluted proteins were boiled and subjected to SDS-PAGE (8-16% gradient gel). Silver staining was applied for visualization. In the negative controls, no RNA was added to the reaction for lane 1; biotin-16-UTP was added to the reaction for lane 2; non-biotinylated RNA was added to the reaction for lane 3. A comparison with the control lanes 1-3 revealed that some protein bands appeared only in lane 4. Those bands were excised, digested in gel, and analyzed by MALDI-TOF. (B) Specific association of FBP2 with EV71 5 0 UTR was confirmed by western blot and competition assay. The pulldown assay that was displayed in Figure 1A was performed here. The eluted proteins were also subjected to SDS-PAGE (12%). Antibody against 10 and 15 ). After the beads were washed, bound proteins were resolved using 12% SDS-PAGE. FBP2 protein was visualized by immunoblot analysis with anti-FBP2 proteins antibody.
FBP2 fused with the FLAG ( Figure 3A) and their ability to interact with EV71 5 0 UTR was tested by RNA-protein pull down assay. These plasmids were transfected individually into RD cells and the cell lysates were utilized in RNA-protein pull down experiments. The expressions of FBP2 (lane 1) and the truncated forms (lanes 4, 7, 10 and 13) were visualized by western blot using anti-flag antibody ( Figure 3B ). Streptavidin beads captured biotinylated EV71 5 0 UTR and its associated full-length FBP2, as well as two truncated forms, FBP2-KH 1-4 and FBP2-KH 2-4 , but not FBP2-KH 1-3 and FBP2-KH [3] [4] . These results suggest that FBP2 may interact with EV71 5 0 UTR through a region that contains at least KH2 and KH4 RNA-binding domains. 4, 6, 8, 10, 12, 14, 16, 18, 20, 22 and 24) . Non-biotinylated RNA probes were as controls (lanes 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21 and 23). After being pulled down by streptavidin beads, the protein complex was dissolved in the SDS-PAGE as described above. Western blot was then applied to detect FBP2 in the pull-down complex. 
EV71 infection redistributes FBP2 to different subcellular compartments
FBP2 is localized in the nucleus, while EV71 replication occurs in the cytoplasm. How FBP2 in the nucleus associates with EV71 5 0 UTR is unclear. To characterize further the cellular localization of FBP2 in EV71-infected cells, their subcellular localization after EV71 infection was compared with that after mock infection by fluorescence microscopy. For this purpose, DNA constructs were generated to express FBP2 fused with the flag. These constructs were transfected into RD cells for 2 days and then the transfected cells were infected by EV71 at 40 MOI; the subcellular distribution of the fusion proteins was analyzed by fluorescence confocal microscopy at 6-h post-infection. In the absence of EV71 infection, FBP2 protein is mainly localized in the nucleus of the cells ( Figure 4A-4) . However, EV71 infection redistributes FBP2 to the cytoplasm ( Figure 4A-9 ). Staining with antibody against viral 3A protein identified the EV71-infected cells. Hoechst 33258 was the dye specific for the nucleus. The data indicate that FBP2 is being relocalized from the nucleus to the cytoplasm or retained in the cytoplasm during EV71 infection.
FBP2 associates with EV71 5' UTR in EV71 infection
FBP2 was determined to redistribute to the cytoplasm upon EV71 infection, and then whether the FBP2 associates with EV71 5 0 UTR in EV71 infected-cells was examined. FBP2/FLAG was overexpressed in RD cells, which were then challenged by EV71 at 40 MOI. After 6, 7 and 8 h EV71 post-infection, the cells were lyzed and the RNAprotein complexes were immunoprecipitated by antibody specific to flag that fused with FBP2 or HA (as a negative control). RNA was isolated from these immunoprecipitates and then subjected to the RT-PCR reaction using with primers specific to either EV71 5 0 UTR or ribosomal protein S16 (RPS16, as a control). At 6, 7 and 
Viral protein synthesis was increased upon knockdown of FBP2 and decreased upon over-expression of FBP2
FBP2 was mapped to interact within the regions of IRES which is reported to participate in viral protein translation. This investigation further examined the synthesis of viral protein in knocked-down FBP2 or over-expressed FBP2. The RNA interference (RNAi) method was applied to investigate the dependency of EV71 translation on FBP2 in vivo. To examine the effect of FBP2 knockdown on EV71 translation, RD cells were transfected with siRNA (NC as negative control or siRNA against FBP2) and then infected with EV71 at 40 MOI. The cells were pulse-labeled with [
35 S] methionine at various times post-infection, and extracts were analyzed by SDS-12% PAGE. Infection with EV71 inhibited the synthesis of host cell protein ( Figure 5A and C) , as expected. The results showed that viral protein synthesis in FBP2-depleted cells exceeded that in NC siRNA-treated cells ( Figure 5A) ; whereas viral protein synthesis in FBP2-overexpressed cells was less than that of control (transfected with FLAG vector only) cells ( Figure 5C ). Figure 5B displays knockdown efficiency of FBP2 and Figure 5D exhibits the over-expression of FBP2. The integrity of cellular protein, eIF4G that has been reportedly cleaved by viral 2A protease shortly after viral infection, was also monitored. This result reveals that FBP2 may participate in viral translation as a negative modulator.
FBP2 negatively regulates IRES-dependent translation of EV71
During EV71 infection, the IRES-mediated initiation of translation allows viral RNA translation. Whether the knockdown or over-expression of FBP2 has any effect on EV71 IRES activity was further examined. A dicistronic reporter plasmid was used to evaluate EV71 IRES activity ( Figure 6A) ; translation of the first cistronic (Renilla luciferase, RLuc) is cap-dependent, whereas the translation of second cistronic (Firefly luciferase, FLuc) is dependent on EV71 IRES activity. Calculating the ratio of FLuc expression to RLuc expression yields the relative IRES activity. First, the siRNA duplex-either NC siRNA or siRNA against FBP2-was transfected to RD cells, and then the siRNA duplex and the dicistronic plasmid were co-transfected into RD cells after 72 h posttransfection. Cell lysates were collected and analyzed to determine RLuc and FLuc activity after 48 h posttransfection. Knockdown of endogenous FBP2 protein increases EV71 IRES activity to 135% (P < 0.001) of that of the NC control ( Figure 6A, left) . The lower panel of 6A presents the knockdown efficiency of FBP2. Moreover, RD cells were transiently transfected with a FLAG-tagged FBP2 or FLAG-expressing plasmid, and the dicistronic plasmid was then transfected into cells after 48 h post-transfection. Cell lyastes were also collected and analyzed to determine RLuc and FLuc activity after 48 h post-transfection. Over-expression of FBP2/FLAG reduced the EV71 IRES activity to 74% (P < 0.05) ( Figure 6A, right) . The lower panel of Figure 6A shows the over-expression efficiency of FBP2. 0 UTR RNA was pulled down with FBP2 from EV71-infected cell extracts. RD cells were transfected with pFlag-CMV2-FBP2. After 2 days, transfected cells were infected by EV71 at 40 MOI. The cell extract was collected 6 h post-infection. Anti-Flag antibody was used in the immunoprecipitation assay. Following washing and dissociation, the RNA was extracted and subjected to the RT-PCR reaction using primers that were specific to either EV71 5 0 UTR or ribosomal protein S16 (RPS16). Cell lysate without immunoprecipitation was used for RNA extraction (lanes 1 and 6) as an RT-PCR control. Anti-Flag antibody was incubated with 200 mg infected cell lysate and then underwent RNA extraction and RT-PCR analysis (lanes 2 and 7) . The same reaction with anti-HA antibody or without antibody was performed used as a negative control (lanes 3, 4, 8 and 9 ). H 2 O as a template was an RT-PCR negative control (lanes 5 and 10). FBP2 protein binds to the EV71 5 0 UTR RNA but not to the control RNA (RPS16).
The direct transfection of dicistronic reporter mRNA was performed. Figure 6B indicates that EV71 IRES activity is increased to 111% (P < 0.05) in FBP2-knockdown cells and reduced to 90% (P < 0.001) in FBP2-overepressed cells. The FLuc/RLuc ratio following DNA transfection may be related to a nuclear event, such as the use of a cryptic promoter or the splice site in the IRES sequence. Accordingly, monocistronic mRNAs that contained the EV71 5 0 UTR were alternatively transfected into RD cells, and the FLuc activity was measured after RD cells were transfected by FBP2 siRNA (knock-down) or FBP2/FLAG (over-expression). The knockdown of endogenous FBP2 protein increased EV71 IRES activity to 132% (P < 0.05) of that of the NC control ( Figure 6C , left). The lower panel of Figure 6C displays the knockdown efficiency of FBP2. RD cells were transiently transfected with a FLAG-tagged FBP2 or FLAG-expressing plasmid, and then the monocistronic mRNA was transfected into cells after 48-h post-transfection. Cell lyastes were also collected and analyzed to determine FLuc activity after 6 h post-transfection. The over-expression of FBP2/FLAG reduced EV71 IRES activity to 57% (P < 0.05) (Figure 6C, right) . These results together indicate that FBP2 may act as a negative regulator of EV71 IRES function.
Mechanism of negative regulation by FBP2
Two hypotheses seek to explain how FBP2 serves as a negative regulator of EV71 IRES. First, FBP2 is an important adenosine-uridine element binding protein (ARE-BP) that is known to influence RNA stability. In this work, the viral RNA integrity was further investigated in FBP2 knocked-down cells. The right panel of Figure 7A reveals that FBP2 was knocked down by its specific siRNA. 40 MOI of EV71 was used to infect cells and viral RNAs were extracted at various times post-infection. Slot-blot assay using a specific RNA probe against either positive or negative sense EV71 viral RNA was employed to monitor viral RNA synthesis. The results in Figure 7A indicate that neither positive nor negative stranded EV71 RNA in FBP2 siRNA-treated cells differed from that in NC siRNA-treated cells.
Another hypothesis is that FBP2 competes with other positive ITAFs to bind with specific EV71 IRES and thereby negatively regulate IRES activity. In vitro competition binding assay was performed. Various amounts of recombinant PTB protein, a positive ITAF of picornavirus, were added to the in vitro binding assay and the results show that FBP2 outcompeted PTB for IRES binding ( Figure 7B ). Taken together, these results support the second hypothesis-that FBP2 may compete with EV71 positive ITAFs, so that FBP2 acts as negative regulator.
DISCUSSION
An internal ribosomal entry site (IRES) that directs the initiation of viral protein translation is a potential drug target for enterovirus 71 (EV71). This investigation identified the trans-acting factors associated with EV71 5 0 UTR to elucidate the mechanism of the initiation of translation on EV71. In the past, the most commonly employed experimental strategy involved either UV cross-linking or electrophoretic mobility-shift assays to identify proteins that interact with picornavirus 5 0 UTR. However, this work utilizes a biotinylated RNA-protein pull-down assay, combined with MALDI-TOF analysis, to provide a global view of cellular proteins that associate with EV71 5 0 UTR. IRES-specific trans-acting factors (ITAFs) that are involved in the functionality of the EV71 IRES are sought and far upstream element binding 2 (FBP2) is identified as a novel EV71 IRES ITAFs. FBP2 is also known as KH-type splicing regulatory protein (KSRP). It is originally identified as a component of a protein complex that assembles on an intronic c-src neuronal-specific splicing enhancer, is an important adenosine-uridine element binding protein (ARE-BP) that is known to interact with several AREs (22, 23) .
This study is first to report that FBP2 binds to the highly structured EV71 5 0 UTR. This fact is demonstrated by RNA affinity capture experiments. It demonstrates that the binding of FBP2 to EV71 5 0 UTR is specific. Its binding to biotinylated EV71 5 0 UTR is not competitively eliminated by non-specific RNA, such as yeast tRNA ( Figure 1B, lanes 8-10) , but is competitively eliminated by cold non-biotinylated EV71 5 0 UTR in a concentration-dependent manner ( Figure 1B, lanes 3-5) . Since FBP2 proteins mostly accumulate in the nuclear compartment (24) , an important question is how a nucleus-localized host protein interacts with EV71 RNA in the cytoplasm and modulates viral replication. Immunofluorescence experiments have indicated that a significant portion of FBP2 is present in the cytoplasm after EV71 infection ( Figure 4A ), where it can interact with EV71 RNA. Co-immunoprecipitation assay is also employed to demonstrate that FBP2 associates with EV71 5 0 UTR in EV71-infected cells ( Figure 4B) .
A single-cycle virus replication assay was conducted in FBP2-knockdown and FBP2-overexpressed cells. Viral yields decreased slightly by less than order of magnitude in FBP2-overexpressed cells, but did not visibly observably differ in FBP2-knockdown cells. FBP2 seemingly modulates viral protein synthesis ( Figure 5 ), but whether FBP2 influences any other cellular process during EV71 infection is unclear. The effect of FBP2 on cellular machinery may reduce viral yields in FBP2 knockdown cells, which then exhibited no observable difference in viral titer when a single-cycle virus was replicated in FBP2-knockdown cells in which viral yields were expected to be increased.
The viral components i.e. viral RNA and viral proteins are made in great excess under normal condition in infected cells. Therefore several fold fluctuation in the amounts of viral proteins would not be expected to reflect in virus yield. As the amounts of viral proteins are surplus in untreated cells, the 'extra' amounts of viral proteins ($2-fold) made in FBP 2-depleted cells would not dramatically increase the virus yield. Similarly, the decreased synthesis of viral proteins ($2-fold) resulted from overexpression of FBP2 would not significantly decrease the virus yield. We therefore would like to emphasize the effect of FBP 2 is mainly on the viral protein synthesis, i.e. the IRES-dependent translation. The growth rate of EV71 was found slower than that of other enteroviruses (PV, CB3, etc). We have performed 'one-step' growth rate analysis and noticed that the viral titer usually peaks and reaches plateau at 12-15 h (data not shown). We also performed extensive time course experiments to monitor the viral translation, and found little viral protein synthesis at early time points by metabolic radiolabeling experiment. As a result the effect of FBP2 on viral protein synthesis was hardly evaluated prior to 6-h post-infection ( Figure 5 ).
Many other proteins that are primarily localized in the nucleus also interact with picornaviral RNA in the cytoplasm. Various nuclear localization cellular factors, such as PTB (25) , hnRNP C (26), hnRNP K (27), hnRNP A1 (28) and nuclear factors (NF45) (29) , interact with picornaviral RNA and affect picornaviral replication and/or translation. The interaction between the nucleus-localized host cellular factors and EV71 RNA provides two important pieces of information for viral-host interactions on EV71 infection. First, EV71 infection may influence the cellular distribution of numerous host proteins, such as hnRNP A1, hnRNP K and hnRNP C (27, 30) and the nuclear factors (NF45) (29) . Second, some of these host proteins, such as PTB (25) , hnRNP C (26) and the nuclear factors (NF45) (29) , may have important, active functions in the viral life cycle.
Why did FBP2 relocalize to cytoplasm-because EV71 RNA simply tethers FBP2 in the cytoplasm or because EV71 infection influences the nuclear-cytoplasmic transport of FBP2? The localization of FBP2 in EV71 IRES reporter construct-transfected cells was examined. FBP2 remained localized in the nuclei of transfected cells ( Figure S1 in the Supplementary Data). The results suggest that EV71 infection but not IRES alone caused the relocalization of FBP2, which also highlights the modest effect of FBP2 knockdown on the EV71 IRES reporter constructs ( Figure 6 ). Therefore, EV71 IRES activity was measured again with co-infection with EV71. Figure S2 in the Supplementary Data presents the results. After 2 h post-infection, monocistronic mRNA that contains EV71 IRES and FLuc as a reporter was transfected into cells. Cell lysates were collected and analyzed to determine FLuc activity after 4 h post-transfection. The results indicate that EV71 infection increased the effect of FBP2 on EV71 IRES activity by a factor of $1.2 times over that of mock-infection.
Two speculated hypotheses seek to explain how FBP2 serves as a negative regulator of EV71 IRES. First, FBP2 is an important ARE-BP that is known to interact with many AREs. The central part of the protein is organized in four K-homology domains. The KH4 domain of FBP2 is essential for mRNA decay and ARE recognition, and its deletion results in the complete loss of these activities (31, 32) . FBP2 interacts with the AU-rich elements that destabilize fos mRNA and with the human exosome complex in vitro. Depletion/addback experiments in a cytoplasmic in vitro degradation system support a role for the protein involvement in targeting mRNAs for degradation (23) . The interaction between FBP2 and EV71 5 0 UTR was verified by mapping the interaction regions to nt 1-167, 91-228 and 566-745 in EV71 5 0 UTR and KH2 and KH4 domains in FBP2 (Figures 2B and 3B ). FBP2 may inhibit EV71 IRES because the binding of Figure 7 . Mechanism of negative regulation by FBP2. (A) Viral RNA synthesis was not affected in FBP2 knock-down cells. After RD cells had been transfected with FBP2 and NC siRNA for 48-h, the cells were reseeded into plates. 24-h thereafter, the cells were infected with EV71 (4643/TW/1998) at 40 MOI and RNA was extracted at various times post-infection. RNA was loaded onto a nitrocellulose sheet in the slotblot manifold. After washing, it was air-dried and crosslinked, and the nitrocellulose was prehybridized. DIG-labeled RNA probes, specific for either the genome or the antigenome were added and incubated. Following washing and blocking, the blots were incubated with chemiluminescent substrate for visualization. (B) FBP2 was outcompeted by PTB recombinant protein for IRES binding. The pull-down assay that was displayed in Figure 1A was performed here. The eluted proteins were subjected to SDS-PAGE (12%). Antibodies against FBP2 and PTB were utilized in western blot analysis. Various amounts of PTB recombinant protein were added to compete with FBP2 in interacting with biotin-labeled EV71 5 0 UTR. In the negative control, nonbiotinylated RNA was added to the reaction in lane 1. PTB competitor was used in the competition assay (lanes 3-6).
FBP2 to EV71 5
0 UTR may destroy the structure of IRES and therefore degrades the viral RNA. Second, some cellular proteins identified from MALDI-TOF in Table 1 were mapped as having the binding sites in EV71 5 0 UTR that overlap with that of FBP2. Such proteins are PTB, hnRNP A1 and FBP (data not shown). This finding raises one possibility that FBP2 may compete with other ITAFs to bind with specific EV71 IRES and thereby regulate IRES activity in a negative manner. An in vitro competition binding assay was performed and the results in Figure 7B reveal that FBP2 outcompeted the binding of PTB. PTB has been demonstrated to be a positive ITAF for other picornaviruses (20, 33) . The result suggests that FBP2 may compete with other ITAFs to act as a negative regulator of EV71 IRES.
The FLuc/RLuc ratio following DNA transfection may also be related to a nuclear event, such as the use of a cryptic promoter or the use of a splicing site in the IRES sequence. Accordingly, monocistronic mRNA was utilized to measure EV71 IRES activity. The results of EV71 IRES activity were consistent with that of a dicistronic construct. All of the results reveal that the knocking down of FBP2 expression increase EV71 IRES activity, while the up-regulation of FBP2 expression reduced EV71 IRES activity ( Figure 6A , B and C). The sequence of the construct was examined and no splicing site was present within EV71 IRES. RT-PCR was also performed to confirm the absence of a splicing product of EV71 IRES RNA ( Figure S3 ).
To our knowledge, this investigation is the first to describe on the molecular level negative regulation by FBP2 of EV71 translation. These studies help not only to understand the function of IRES but also further investigations of the mechanism by which cellular proteins are involved in EV71 infection.
